Genomics into health
As genomic experts, we have a comprehensive understanding of how innovative technologies can contribute to more effective healthcare
We work with policy-makers, clinicians, academia and industry to develop future-focused healthcare strategies for safe and suitable use of innovations, such as diagnostics, genome editing and regenerative medicines. Only through understanding the benefits - and complexities - of genomics-based innovations and other 'omics sciences can we help everyone benefit from great science.
PHG Foundation is collaborating with organisations across Europe to create a 'Personalised Prevention Roadmap'.
Blog Host genomics and COVID-19: where are we now?
25 October 2021
COVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.
Explainer Host genomics and infectious disease
22 September 2021
Genomic factors can explain why different people (hosts) may have more or less severe symptoms or no symptoms when infected by the same pathogen.
Blog Long reads
6 September 2021
Some things are just too interesting to reduce to a few hundred words. The PHG Foundation's long read series takes a deeper dive into areas of new science and their implications for health policy
Briefing Antisense oligonucleotide therapies
3 September 2021
Policy briefing on ASOs and their RNA molecule targeting
16 August 2021
What is pharmacogenomics?
Explainer Nutritional genomics
29 July 2021
Nutrients in our diet affect how our bodies function and our overall health.
Explainer Microbiome analysis and manipulation
27 July 2021
A short overview of the potential healthcare uses of understanding the microbiome